Virtus ETF Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,485
| Closed | -$59.8K | – | 661 |
|
2024
Q4 | $59.8K | Sell |
1,485
-286
| -16% | -$11.5K | 0.02% | 451 |
|
2024
Q3 | $112K | Buy |
1,771
+33
| +2% | +$2.09K | 0.05% | 360 |
|
2024
Q2 | $92.1K | Sell |
1,738
-2,773
| -61% | -$147K | 0.05% | 350 |
|
2024
Q1 | $370K | Sell |
4,511
-306
| -6% | -$25.1K | 0.2% | 206 |
|
2023
Q4 | $89.6K | Buy |
4,817
+399
| +9% | +$7.43K | 0.06% | 405 |
|
2023
Q3 | $48.9K | Sell |
4,418
-439
| -9% | -$4.86K | 0.03% | 416 |
|
2023
Q2 | $78.7K | Buy |
+4,857
| New | +$78.7K | 0.05% | 430 |
|
2022
Q2 | – | Sell |
-32,708
| Closed | -$98K | – | 476 |
|
2022
Q1 | $98K | Sell |
32,708
-1,945
| -6% | -$5.83K | 0.04% | 307 |
|
2021
Q4 | $159K | Sell |
34,653
-318
| -0.9% | -$1.46K | 0.06% | 328 |
|
2021
Q3 | $220K | Sell |
34,971
-1,820
| -5% | -$11.4K | 0.1% | 244 |
|
2021
Q2 | $220K | Sell |
36,791
-7,964
| -18% | -$47.6K | 0.09% | 276 |
|
2021
Q1 | $283K | Buy |
44,755
+789
| +2% | +$4.99K | 0.12% | 251 |
|
2020
Q4 | $248K | Buy |
43,966
+1,459
| +3% | +$8.23K | 0.1% | 315 |
|
2020
Q3 | $247K | Sell |
42,507
-5,813
| -12% | -$33.8K | 0.13% | 267 |
|
2020
Q2 | $348K | Buy |
48,320
+3,100
| +7% | +$22.3K | 0.16% | 266 |
|
2020
Q1 | $212K | Sell |
45,220
-6,603
| -13% | -$31K | 0.09% | 273 |
|
2019
Q4 | $416K | Buy |
51,823
+19,672
| +61% | +$158K | 0.07% | 243 |
|
2019
Q3 | $221K | Sell |
32,151
-1,790
| -5% | -$12.3K | 0.04% | 231 |
|
2019
Q2 | $282K | Buy |
33,941
+5,087
| +18% | +$42.3K | 0.06% | 244 |
|
2019
Q1 | $287K | Sell |
28,854
-3,457
| -11% | -$34.4K | 0.61% | 62 |
|
2018
Q4 | $247K | Sell |
32,311
-7,649
| -19% | -$58.5K | 0.04% | 161 |
|
2018
Q3 | $696K | Sell |
39,960
-29,345
| -42% | -$511K | 0.07% | 75 |
|
2018
Q2 | $658K | Buy |
+69,305
| New | +$658K | 0.58% | 119 |
|